Better Buy: GW Pharmaceuticals vs. Cara Therapeutics


Small biotech stocks can provide investors with opportunities to make big gains — assuming the companies win regulatory approval for their drug candidates and transform from money sinks into cash generators. They can also fail spectacularly, punishing investors severely. Two companies with near-term catalysts on the horizon and reasonable chances of becoming profitable are GW Pharmaceuticals (NASDAQ: GWPH) and Cara Therapeutics (NASDAQ: CARA) .

Ga naar Bron